Serum phosphate as an additional marker for initiating hemodialysis in patients with advanced chronic kidney disease

by Yueh-An Lu, Shen-Yang Lee, Hui-Yi Lin, Yen-Chun Liu, Huang-Kai Kao, Yung-Chang Chen, Ya-Chung Tian, Cheng-Chieh Hung, Chih-Wei Yang, Hsiang-Hao Hsu
Published 2015-12-01

Nutritional Guideline for the Management of Mexican Patients with CKD and Hyperphosphatemia

by Frida Palafox-Serdán, Olinto A. Luna-Montiel, Sebastián E. Pablo-Franco, Daniela L. Guillen-Tejada, Sandra D. Carreño-Vázquez, Taísa S. Silva Pereira, Laura M. Islas Romero, Karen Villaseñor López, Ana E. Ortega-Régules, Aura M. Jiménez-Garduño
Published 2020-10-01

Vascular Calcification: An Important Understanding in Nephrology

by Zununi Vahed S, Mostafavi S, Hosseiniyan Khatibi SM, Shoja MM, Ardalan M
Published 2020-05-01

Intensified treatment of hyperphosphatemia associated with reduction in parathyroid hormone in patients on maintenance hemodialysis

by Lan Chen, Jin-Xuan He, Ying-Ying Chen, Yi-Sheng Ling, Chun-Hua Lin, Tian-Jun Guan
Published 2018-10-01

Extracellular Vesicles As Mediators of Cardiovascular Calcification

by Amirala Bakhshian Nik, Joshua D. Hutcheson, Elena Aikawa, Elena Aikawa
Published 2017-12-01

Phosphate stimulates myotube atrophy through autophagy activation: evidence of hyperphosphatemia contributing to skeletal muscle wasting in chronic kidney disease

by Yue-yue Zhang, Man Yang, Jin-fang Bao, Li-jie Gu, Hong-lei Yu, Wei-jie Yuan
Published 2018-02-01

The effect of intravenous vitamin C on the phosphorus level reduction in hemodialysis patients: A double blind randomized clinical trial

by Afshin Gholipour Baradari, Amir Emami Zeydi, Fatemeh Espahbodi, Mohsen Aarabi
Published 2012-02-01

Hyperphosphatemia-Induced Oxidant/Antioxidant Imbalance Impairs Vascular Relaxation and Induces Inflammation and Fibrosis in Old Mice

by Ana Asenjo-Bueno, Elena Alcalde-Estévez, Mariam El Assar, Gemma Olmos, Patricia Plaza, Patricia Sosa, Patricia Martínez-Miguel, María Piedad Ruiz-Torres, Susana López-Ongil
Published 2021-08-01

Hypoparathyroidism: disease update and new methods of treatment

by Tatiana A. Grebennikova, Zhanna E. Belaya, Galina A. Melnichenko
Published 2017-09-01

Hyperphosphatemia in chronic kidney disease

by S. A. Martynov, M. Sh. Shamkhalova
Published 2019-10-01

Prevention and Treatment of Tumor Lysis Syndrome in the Era of Onco-Nephrology Progress

by Joanna Matuszkiewicz-Rowinska, Jolanta Malyszko
Published 2020-09-01

Hyperphosphatemia and risks of acute kidney injury, end-stage renal disease, and mortality in hospitalized patients

by Hongran Moon, Ho Jun Chin, Ki Young Na, Kwon Wook Joo, Yon Su Kim, Sejoong Kim, Seung Seok Han
Published 2019-09-01

Hyperphosphatemia Drives Procoagulant Microvesicle Generation in the Rat Partial Nephrectomy Model of CKD

by Nima Abbasian, Alison H. Goodall, James O. Burton, Debbie Bursnall, Alan Bevington, Nigel J. Brunskill
Published 2020-11-01

A rare case of spontaneous tumor lysis syndrome in multiple myeloma

by Louay Aldabain, Lyn Camire, David S. Weisman
Published 2020-07-01

Vascular Calcification—New Insights Into Its Mechanism

by Sun Joo Lee, In-Kyu Lee, Jae-Han Jeon
Published 2020-04-01

Effect of low dose nicotinic acid on hyperphosphatemia in patients with end stage renal disease

by N S Zahed, N Zamanifar, H Nikbakht
Published 2016-01-01

Efficacy and Safety of Sucroferric Oxyhydroxide and Calcium Carbonate in Hemodialysis Patients

by Fumihiko Koiwa, Keitaro Yokoyama, Masafumi Fukagawa, Tadao Akizawa
Published 2018-01-01

Update on tumor lysis syndrome management

by P Angsuwatcharakon, P Sunpaweravong
Published 2006-08-01

Treatment of phosphate retention: The earlier the better?

by Patrick Biggar, Samuel K.S. Fung, Markus Ketteler
Published 2014-03-01